mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-05 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |